Bluestar Genomics Funding: $70M Raised, Series C (2021)
Bluestar Genomics is based in San Diego, CA. It has raised $70M in total funding. Latest round: Series C.
Bluestar Genomics funding overview
Bluestar Genomics is based in San Diego, CA. Bluestar Genomics has raised $70M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in May 2021. The round record for Bluestar Genomics runs through 2021; nothing later has been disclosed. Investors on record include Prosperity Capital Management, Pathology Asia Holdings Pte Ltd. 2 distinct backers are named across the disclosed rounds.
Bluestar Genomics at a glance
Total raised
$70M
Latest round
Series C
Latest round date
May 2021
Headquarters
San Diego, CA
Notable investors
Prosperity Capital Management, Pathology Asia Holdings Pte Ltd
Frequently asked about Bluestar Genomics funding
How much has Bluestar Genomics raised?
Bluestar Genomics has raised $70M in total disclosed funding across the rounds on record.
Who has invested in Bluestar Genomics?
Prosperity Capital Management, Pathology Asia Holdings Pte Ltd are named among the investors backing Bluestar Genomics.
What was the latest Bluestar Genomics funding round?
The most recent disclosed round is a Series C, announced in May 2021.
Where is Bluestar Genomics based?
Bluestar Genomics is based in San Diego, CA.
When did Bluestar Genomics last raise?
The last disclosed Bluestar Genomics round closed in May 2021 at Series C.
Totals shown for Bluestar Genomics aggregate every disclosed round on file. To see how that compares, browse the companies in San Diego and the investors behind them below.
